Skip to content

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder

Optimizing Treatment for Alcohol Use Disorder (AUD) Using Targeted Transcranial Magnetic Stimulation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03969251
Enrollment
14
Registered
2019-05-31
Start date
2019-07-11
Completion date
2021-02-10
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism

Keywords

alcohol, alcohol dependence, addiction, alcohol use disorder

Brief summary

This is a pilot study designed to evaluate the efficacy of High Frequency (HF) repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (L-DLPFC) at improving cognitive flexibility in recently detoxified individuals with alcohol use disorder (AUD) compared to placebo (Sham rTMS). The total number of subjects requested to be randomized is 20. The investigator will need to screen about 40 subjects to have 20 subjects started on rTMS session at a ratio of 2 screens/1 subject randomized.

Detailed description

This is a randomized double- blind, control study. To test the hypothesis, the investigator propose a 2 phase design: Phase 1: 6-week trial comparing the efficacy of active high-frequency (HF) rTMS of L-DLPFC versus sham (SS) rTMS to determine if HF rTMS improves cognitive flexibility in recently detoxified alcoholics Phase 2: at the end of TMS phase, all participants will receive cognitive behavioral therapy (CBT) thus permitting participants with AUD to benefit from cognitive restructuring in CBT, and reduce alcohol cravings and drinking outcomes. This study will recruit 20 individuals with AUD, comprising of both male and female participants, age 22 years and older interested in alcohol drinking abstinence. Participants will be recruited from the inpatient unit upon discharge after receiving a detoxification treatment and therefore will be abstinent at study entry. Prior to treatment onset and weekly throughout the course of treatment, participants will complete cognitive testing/measures, Wisconsin Card Sorting Task (WCST), Dimensional Change Card Sort Task (DCCST), Barratt Impulsiveness Scale (BIS), Flanker Inhibitory Control and Attention Test (FICAT), and List Sorting Working Memory Test (LSWMT) and self-reported craving measures, Alcohol Craving Questionnaire (ACQ-Now), and Obsessive Compulsive Drinking Scale (OCDS). The drinking timeline follow-back, and adverse events will also be assessed weekly for 8 weeks. Participant will be randomized to either high frequency (HF) or sham repetitive transcranial magnetic stimulation (SS rTMS), which will be done 5 days per week for 6 weeks. At the end of 6 weeks, all participants will receive weekly CBT for a total of 8 weeks. Participants will return at 2 and 4 weeks for follow-up assessments.

Interventions

active high frequency repetitive TMS of left Dorsolateral Prefrontal Cortex

DEVICESham (SS)

repetitive sham rTMS

Sponsors

Nassima Ait-Daoud Tiouririne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Right handed males and females who have given written informed consent. * Age 22 years and above with a history of alcohol use disorder * Good physical health * Have a current diagnosis of alcohol use disorder * Reports at least 4 "heavy drinking days" on average in the past 30 days. * Have a BAC by breathalyzer equal to 0.000 when the participants signed the informed consent document * Six months stability on any psychotropic medications * Not have any unresolved legal problems that could jeopardize continuation or completion of the study. * Be able to provide written informed consent, able to understand written and oral instructions in English and be able to complete the questionnaires required by the protocol.

Exclusion criteria

Please contact site for additional information.

Design outcomes

Primary

MeasureTime frameDescription
Wisconsin Card Sorting Test (WCST)Up to 5 monthsThis is a neuropsychological task that measures flexibility in thinking, or "set shifting," during changing reinforcement schedules.
Dimensional Change Card Sort Task (DCCST)Up to 5 monthsThis is a neuropsychological task that measures cognitive flexibility and attention.
Flanker Inhibitory Control and Attention Test (FICAT)Up to 5 monthsThis is a neuropsychological task that measures attention and inhibitory control.
List Sorting Working Memory Test (LSWMT)Up to 5 monthsThis is a neuropsychological task that measures working memory.

Secondary

MeasureTime frameDescription
Drinks Per Drinking DayUp to 5 monthsThe investigator will use timeline follow-back to capture this drinking outcome.
Percentage of Days of AbstinenceUp to 5 monthsThe investigator will use timeline follow-back to capture this drinking outcome.
Percentage of Heavy Drinking DaysUp to 5 monthsThe investigator will use timeline follow-back to capture this drinking outcome.
Alcohol Craving Questionnaire (ACQ-NOW)Up to 5 monthsThis is a 47-item self-administered, multidimensional state measure of acute alcohol craving adapted from the Cocaine Craving Questionnaire. It measures the subscales of alcohol craving labeled Emotionality, Purposefulness, Compulsivity, and Expectancy.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNassima Ait-Daoud TIouririne, M.D.

University of Virginia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026